immunotherapy
29
Nov
Novel nanoparticles deliver innovative cancer chemoimmunotherapy
Cancer chemoimmunotherapy is an emerging field of cancer treatment that harnesses the body’s own immune system to fight tumor cells. Na...
01
Nov
Why immunotherapy works well for some cancer patients, but not others
Immunotherapy is a cancer treatment that harnesses the body’s own immune system to fight cancer cells. It can be effective in treating...
27
Oct
Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma
Neoadjuvant immunotherapy with the anti-PD-1 antibodies relatlimab and nivolumab is safe and effective in stage III melanoma, according...
03
Oct
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups.
Cancer immunotherapy ...
30
Sep
Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy
A new study has found that patients with advanced melanoma who are given immunotherapy before targeted therapy have significantly impro...
20
Sep
Melanoma treatment: Potential target bypasses therapeutic resistance to immune checkpoint blockers
In the last few years, there has been an immunotherapy revolution in the treatment of cancer. Therapies that take advantage of the immu...
19
Sep
Immunotherapy reduces lung and liver fibrosis in mice
Immunotherapy using a novel antibody reduces lung and liver fibrosis in mice, according to new research. The study provides insight int...
18
Sep
Experimental test promises to predict side-effects and cancer’s return in patients treated with immunotherapy
A new experimental test may be able to predict if a patient's cancer will return after being treated with immunotherapy. The test looks...